Decibel Therapeutics Inc. (NASDAQ: DBTX) stock closed at 4.91 per share at the end of the most recent trading day (a -0.81% change compared to the prior day closing price) with a volume of 1.06M shares and market capitalization of 123.37M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 37 people. Decibel Therapeutics Inc. CEO is Laurence E. Reid.

The one-year performance of Decibel Therapeutics Inc. stock is 26.6%, while year-to-date (YTD) performance is 139.51%. DBTX stock has a five-year performance of %. Its 52-week range is between 1.61 and 5.4, which gives DBTX stock a 52-week price range ratio of 87.07%

Decibel Therapeutics Inc. currently has a PE ratio of -1.10, a price-to-book (PB) ratio of 0.65, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -36.62%, a ROC of -43.55% and a ROE of -47.79%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Decibel Therapeutics Inc., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.61 for the next earnings report. Decibel Therapeutics Inc.’s next earnings report date is 08th Nov 2023.

The consensus rating of Wall Street analysts for Decibel Therapeutics Inc. is Hold (3), with a target price of $14.33, which is 0.00% compared to the current price. The earnings rating for Decibel Therapeutics Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Decibel Therapeutics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Decibel Therapeutics Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 17.25, ATR14 : 0.15, CCI20 : -132.56, Chaikin Money Flow : -0.41, MACD : 0.12, Money Flow Index : 41.61, ROC : -3.91, RSI : 51.68, STOCH (14,3) : 9.09, STOCH RSI : 0.00, UO : 38.64, Williams %R : -90.91), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Decibel Therapeutics Inc. in the last 12-months were: